Trials / Sponsors / Andrés José Maria Ferreri
Andrés José Maria Ferreri
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-Cell Lymphoma | — | 2025-12-10 |
| Recruiting | Study to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) Relapsed/Refractory Follicular Lymphoma | — | 2025-12-01 |
| Completed | Molecular Characterization and Outcomes of Aggressive B-Cell Lymphomas. Diffuse Large B Cell Lymphoma (DLBCL) | — | 2022-07-12 |
| Completed | High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System Involvement B-cell Lymphomas | Phase 2 | 2007-01-01 |